NASDAQ: BKYIBio Key International Inc Stock
$1.64-0.02 (-1.2%)
Updated Apr 23, 2024
BKYI Price
$1.64
Fair Value Price
N/A
Market Cap
$1.25M
52 Week Low
$1.49
52 Week High
$15.30
P/E
-0.08x
P/B
0.38x
P/S
0.57x
PEG
N/A
Dividend Yield
N/A
Revenue
$8.59M
Earnings
-$8.91M
Gross Margin
66.4%
Operating Margin
-99.9%
Profit Margin
-103.7%
Debt to Equity
1.94
Operating Cash Flow
-$4M
Beta
-0.05
Next Earnings
May 13, 2024
Ex-Dividend
N/A
Next Dividend
N/A
BKYI Overview
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BKYI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BKYI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BKYI is good value based on its book value relative to its share price (0.38x), compared to the US Security & Protection Services industry average (3x)
P/B vs Industry Valuation
BKYI is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more BKYI due diligence checks available for Premium users.
Be the first to know about important BKYI news, forecast changes, insider trades & much more!
BKYI News
Valuation
BKYI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.08x
Industry
38.98x
Market
41.92x
BKYI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.38x
Industry
3x
BKYI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BKYI's financial health
Profit margin
Revenue
$1.8M
Net Income
-$637.8k
Profit Margin
-35.1%
BKYI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
BKYI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$9.7M
Liabilities
$6.4M
Debt to equity
1.94
BKYI's short-term assets ($7.82M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BKYI's short-term assets ($7.82M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BKYI's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
BKYI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$166.7k
Investing
$0.0
Financing
-$83.1k
BKYI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
BKYI vs Security & Protection Service Stocks
Bio Key International Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.